fibrinogen has been researched along with Lymphangioleiomyomatosis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bagwe, S; Cui, Y; El-Chemaly, S; Goldberg, HJ; Henske, EP; Lamattina, AM; Moss, J; Rosas, IO; Taveira-Dasilva, A | 1 |
1 trial(s) available for fibrinogen and Lymphangioleiomyomatosis
Article | Year |
---|---|
Circulating Biomarkers From the Phase 1 Trial of Sirolimus and Autophagy Inhibition for Patients With Lymphangioleiomyomatosis.
Topics: Acetyl-CoA Carboxylase; Adult; Biomarkers; Correlation of Data; Drug Monitoring; Drug Therapy, Combination; Enzyme Inhibitors; Female; Fibrinogen; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lung Diseases; Lymphangioleiomyomatosis; Respiratory Function Tests; Sirolimus; Vascular Endothelial Growth Factor Receptor-3 | 2018 |